As of November 7, 2026, SmartKem, Inc. has Schedule 13D or 13G filings on record, none whose latest reports a stake of 5% or more. 9 filings are on record since July 1, 2025 (Schedule 13G/A, August 4, 2026).
Sell to companies like SmartKem, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Lizzio Joseph Christopher · Sole voting: 239,000 · Shared voting: 180,000 · Sole dispositive: 239,000 · Shared dispositive: 180,000 · SCHEDULE 13G/A, 2026-08-04
- · Reporting person: Orin Hirschman · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 1,095,791 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-07-27
- · Holder: Orin Hirschman · Percent: 9.9% · SCHEDULE 13G/A
- · Holder: Five Narrow Lane LP · Percent: 4.69% · SCHEDULE 13G/A
- · Holder: Bleichroeder LP · Percent: 4.1% · SCHEDULE 13G/A
SmartKem, Inc. has 9 Schedule 13D or 13G filings on record since 2025-07-01. No holder's latest filing reports 5% or more. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| MYDA Advisors LLC | 4.9% | 217,127 | SCHEDULE 13G/A, 2025-07-01 | 2025-06-30 |
| 4.9% | 1,095,791 | SCHEDULE 13G/A, 2026-07-27 | 2026-06-30 | |
| Five Narrow Lane LP | 4.69% | 287,187 | SCHEDULE 13G/A, 2026-01-21 | 2025-12-31 |
| Bleichroeder LP | 4.1% | 231,666 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| 1.62% | 419,000 | SCHEDULE 13G/A, 2026-08-04 | 2026-06-30 |
Holding shares or following this stake? See who's behind SmartKem, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on SmartKem, Inc. and the records around it.
SmartKem, Inc. elsewhere on the record
Companies that share a holder
- MYDA Advisors LLC also filed stake reports on 1 other company: Energous Corporation (Apr 2026)
- Five Narrow Lane LP also filed stake reports on 4 other companies: Expion Energy, Inc. (Aug 2026), BLACKBOXSTOCKS INC. (Apr 2026), INVO FERTILITY, INC. (Jan 2026)
- Bleichroeder LP also filed stake reports on 16 other companies: MDxHealth SA (Oct 2026), Identiv, Inc. (INVE) (Aug 2026), Cellectar Biosciences, Inc. (Aug 2026)
Watch SmartKem, Inc.
Get an email when SmartKem, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on SmartKem, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on SmartKem, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SmartKem, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Orin Hirschman | 0 | 0 | 1,095,791 | 0 | SCHEDULE 13G/A, 2026-07-27 |
| AIGH Capital Management LLC | 0 | 0 | 1,095,791 | 0 | SCHEDULE 13G/A, 2026-07-27 |
| Lizzio Joseph Christopher | 239,000 | 180,000 | 239,000 | 180,000 | SCHEDULE 13G/A, 2026-08-04 |
The latest filing identifies SmartKem, Inc. by CUSIP 83193D203 and gives its principal executive office as 3 GERMAY DRIVE, UNIT 4 #1029, DELAWARE, DE 19804 (SCHEDULE 13G/A, 2026-08-04).
What the percentages are based on
The following percentages are based on 25,862,643 shares of Common Stock outstanding as of July 27, 2026 based upon the Issuer's Form 8-K filed with the Securities and Exchange Commission on July 27, 2026.Lizzio Joseph Christopher, SCHEDULE 13G/A, 2026-08-04
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-01 | MYDA Advisors LLC | 4.9% | SCHEDULE 13G/A |
| 2025-08-14 | Bleichroeder LP | 5.04% | SCHEDULE 13G/A |
| 2025-09-24 | Lizzio Joseph Christopher | 7.65% | SCHEDULE 13G |
| 2025-11-12 | Five Narrow Lane LP | 7.49% | SCHEDULE 13G/A |
| 2025-11-14 | Bleichroeder LP | 4.1% | SCHEDULE 13G/A |
| 2026-01-21 | Five Narrow Lane LP | 4.69% | SCHEDULE 13G/A |
| 2026-01-30 | Orin Hirschman | 9.9% | SCHEDULE 13G/A |
| 2026-07-27 | Orin Hirschman | 4.9% | SCHEDULE 13G/A |
| 2026-08-04 | Lizzio Joseph Christopher | 1.62% | SCHEDULE 13G/A |
Also on the record for SmartKem, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 4, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| April 17, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| December 31, 2024 | Form D, private offering | $7.65M sold | Form D page | Source |
Tools for this story
Each opens in a new tab, filled in for SmartKem, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.